Literature DB >> 19652039

Managing osteoporosis: challenges and strategies.

E Michael Lewiecki1.   

Abstract

Many patients at high risk of fracture are not being identified and treated, and many of those who start treatment do not take it correctly or long enough to lower their risk. This paper is a review of unmet needs in the management of osteoporosis and strategies to improve clinical outcomes.

Entities:  

Mesh：

Year:  2009        PMID： 19652039     DOI： 10.3949/ccjm.76a.09019

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  11 in total

1.  Integrated model for denosumab and ibandronate pharmacodynamics in postmenopausal women.

Authors:  Dhananjay D Marathe; Anshu Marathe; Donald E Mager
Journal:  Biopharm Drug Dispos       Date:  2011-09-22       Impact factor: 1.627

2.  siRNA knock-down of RANK signaling to control osteoclast-mediated bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Pharm Res       Date:  2010-03-24       Impact factor: 4.200

3.  Automated opportunistic osteoporotic fracture risk assessment using computed tomography scans to aid in FRAX underutilization.

Authors:  Noa Dagan; Eldad Elnekave; Noam Barda; Orna Bregman-Amitai; Amir Bar; Mila Orlovsky; Eitan Bachmat; Ran D Balicer
Journal:  Nat Med       Date:  2020-01-13       Impact factor: 53.440

Review 4.  Denosumab: a review of its use in the treatment of postmenopausal osteoporosis.

Authors:  Marit D Moen; Susan J Keam
Journal:  Drugs Aging       Date:  2011-01-01       Impact factor: 3.923

5.  Hip structural changes and fracture risk in osteopenia and osteoporosis.

Authors:  Meltem Esenyel; Aynur Ozen; Cem Zeki Esenyel; Aylin Rezvani; Mustafa Akif Sariyildiz; Onder Ergin
Journal:  Eurasian J Med       Date:  2011-08

6.  Bisphosphonates for the treatment of osteoporosis: insights for clinicians.

Authors:  E Michael Lewiecki
Journal:  Ther Adv Chronic Dis       Date:  2010-05       Impact factor: 5.091

7.  An evaluation of clinical risk factors for estimating fracture risk in postmenopausal osteoporosis using an electronic medical record database.

Authors:  S Unni; Y Yao; N Milne; K Gunning; J R Curtis; J LaFleur
Journal:  Osteoporos Int       Date:  2014-10-07       Impact factor: 4.507

Review 8.  Increased fracture rate in women with breast cancer: a review of the hidden risk.

Authors:  Jean-Jacques Body
Journal:  BMC Cancer       Date:  2011-08-29       Impact factor: 4.430

9.  Clinical decision support system for the management of osteoporosis compared to NOGG guidelines and an osteology specialist: a validation pilot study.

Authors:  Haukur T Gudmundsson; Karen E Hansen; Bjarni V Halldorsson; Bjorn R Ludviksson; Bjorn Gudbjornsson
Journal:  BMC Med Inform Decis Mak       Date:  2019-02-01       Impact factor: 2.796

10.  Phenotypic dissection of bone mineral density reveals skeletal site specificity and facilitates the identification of novel loci in the genetic regulation of bone mass attainment.

Authors:  John P Kemp; Carolina Medina-Gomez; Karol Estrada; Beate St Pourcain; Denise H M Heppe; Nicole M Warrington; Ling Oei; Susan M Ring; Claudia J Kruithof; Nicholas J Timpson; Lisa E Wolber; Sjur Reppe; Kaare Gautvik; Elin Grundberg; Bing Ge; Bram van der Eerden; Jeroen van de Peppel; Matthew A Hibbs; Cheryl L Ackert-Bicknell; Kwangbom Choi; Daniel L Koller; Michael J Econs; Frances M K Williams; Tatiana Foroud; M Carola Zillikens; Claes Ohlsson; Albert Hofman; André G Uitterlinden; George Davey Smith; Vincent W V Jaddoe; Jonathan H Tobias; Fernando Rivadeneira; David M Evans
Journal:  PLoS Genet       Date:  2014-06-19       Impact factor: 5.917
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.